Cumberland pharmaceuticals inc. reports earnings results for the third quarter ended september 30, 2019

Cumberland pharmaceuticals inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced sales was usd 10.371 million compared to usd 8.492 million a year ago. operating loss was usd 1.847 million compared to usd 1.806 million a year ago. net loss was usd 1.953 million compared to usd 1.643 million a year ago. basic loss per share was usd 0.13 compared to usd 0.11 a year ago. for the nine months, sales was usd 33.855 million compared to usd 27.243 million a year ago. operating loss was usd 2.625 million compared to usd 5.128 million a year ago. net loss was usd 2.577 million compared to usd 4.742 million a year ago. basic loss per share was usd 0.17 compared to usd 0.3 a year ago.
CPIX Ratings Summary
CPIX Quant Ranking